These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8931614)

  • 1. Changing trends in U.S. prostate cancer incidence rates.
    Merrill RM; Potosky AL; Feuer EJ
    J Natl Cancer Inst; 1996 Nov; 88(22):1683-5. PubMed ID: 8931614
    [No Abstract]   [Full Text] [Related]  

  • 2. Racial disparities in prostate cancer incidence rates by census division in the United States, 1999-2008.
    Cook MB; Rosenberg PS; McCarty FA; Wu M; King J; Eheman C; Anderson WF
    Prostate; 2015 May; 75(7):758-63. PubMed ID: 25619191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
    Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB
    Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial comment.
    Mohler JL
    J Urol; 2010 May; 183(5):1797. PubMed ID: 20299053
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
    Hankey BF; Feuer EJ; Clegg LX; Hayes RB; Legler JM; Prorok PC; Ries LA; Merrill RM; Kaplan RS
    J Natl Cancer Inst; 1999 Jun; 91(12):1017-24. PubMed ID: 10379964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultraviolet index and racial differences in prostate cancer incidence and mortality.
    Taksler GB; Cutler DM; Giovannucci E; Smith MR; Keating NL
    Cancer; 2013 Sep; 119(17):3195-203. PubMed ID: 23744754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial comment.
    Moreira DM; Bañez LL; Freedland SJ
    J Urol; 2010 May; 183(5):1796. PubMed ID: 20299054
    [No Abstract]   [Full Text] [Related]  

  • 8. Stat bite: prostate cancer incidence and mortality in U.S. blacks and whites, 1973-1997.
    J Natl Cancer Inst; 2000 Dec; 92(23):1875. PubMed ID: 11106676
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of reporting delay and reporting error on cancer incidence rates and trends.
    Clegg LX; Feuer EJ; Midthune DN; Fay MP; Hankey BF
    J Natl Cancer Inst; 2002 Oct; 94(20):1537-45. PubMed ID: 12381706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity.
    Powell IJ; Bock CH; Ruterbusch JJ; Sakr W
    J Urol; 2010 May; 183(5):1792-6. PubMed ID: 20299055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partitioned prostate cancer prevalence estimates: an informative measure of the disease burden.
    Merrill RM
    J Epidemiol Community Health; 2001 Mar; 55(3):191-7. PubMed ID: 11160174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence-corrected prostate cancer incidence rates and trends.
    Merrill RM; Morris MK
    Am J Epidemiol; 2002 Jan; 155(2):148-52. PubMed ID: 11790678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stat bite: Prostate cancer incidence and mortality among white and black men, 1975-2000.
    J Natl Cancer Inst; 2003 Sep; 95(18):1357. PubMed ID: 13130106
    [No Abstract]   [Full Text] [Related]  

  • 14. Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals.
    Platz EA; Rimm EB; Willett WC; Kantoff PW; Giovannucci E
    J Natl Cancer Inst; 2000 Dec; 92(24):2009-17. PubMed ID: 11121463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.
    Underwood W; Jackson J; Wei JT; Dunn R; Baker E; Demonner S; Wood DP
    Cancer; 2005 Feb; 103(3):538-45. PubMed ID: 15612083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-adjusted incidence rates for prostate cancer in the United States.
    Merrill RM; Sloan A
    Prostate; 2012 Feb; 72(2):181-5. PubMed ID: 21538427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in prostate carcinoma incidence in Connecticut (1988-1994) by age and race.
    Polednak AP
    Cancer; 1997 Jan; 79(1):99-103. PubMed ID: 8988732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased incidence of prostate cancer in black patients.
    Bowden GB
    Am Fam Physician; 1999 Mar; 59(6):1402, 1405-6. PubMed ID: 10193586
    [No Abstract]   [Full Text] [Related]  

  • 19. Survival rates of prostate cancer: black vs white patients.
    Ethn Dis; 2003; 13(2):298-9. PubMed ID: 12785430
    [No Abstract]   [Full Text] [Related]  

  • 20. Black-white differences in survival from late-stage prostate cancer.
    Polednak AP
    Ethn Dis; 2003; 13(2):220-5. PubMed ID: 12785419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.